Product How it works Pricing Blog FAQ About Contact
ADMA Biologics

ADMA Biologics (NASDAQ: ADMA) net income

ADMA Biologics reported a net profit of $146.9m for fiscal 2025, 25.7% less than in fiscal 2024 ($197.7m). Its net margin was 28.8%. Earnings per share were $0.62.

ADMA Biologics's best year of the last 10 was fiscal 2024. The biggest drop was in fiscal 2025, −25.7%. It reported a loss in 8 of those 10 years.

Net income, in millions of US dollars-19.52016-43.82017-65.72018-48.32019-75.72020-71.62021-65.92022-28.22023197.72024146.92025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$146.9m−25.7%28.8%$0.62
2024$197.7m—46.4%$0.85
2023−$28.2m—−10.9%−$0.13
2022−$65.9m—−42.8%−$0.33
2021−$71.6m—−88.5%−$0.51
2020−$75.7m—−179.4%−$0.88
2019−$48.3m—−164.5%—
2018−$65.7m—−387.1%—
2017−$43.8m—−192.3%—
2016−$19.5m—−183.1%—

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

ADMA Biologics net income compared with its sector

By net income for its latest fiscal year, ADMA Biologics ranks 103rd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of ADMA Biologics, 28.8%.

RankCompanyNet incomeNet margin
101stHarmony Biosciences$158.7m18.3%
102ndBausch Health Companies$157.0m1.5%
103rdADMA Biologics$146.9m28.8%
104thInspire Medical Systems$145.4m15.9%
105thArdent Health$135.8m2.1%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of ADMA Biologics

How much did ADMA Biologics earn in fiscal 2025?
ADMA Biologics reported a net profit of $146.9m for fiscal 2025. In fiscal 2024 it reported a net profit of $197.7m.
What are the earnings per share of ADMA Biologics?
They were $0.62 in fiscal 2025, compared with $0.85 in fiscal 2024.
What is the net margin of ADMA Biologics?
In fiscal 2025 its net profit was 28.8% of its revenue.
What was the most profitable year for ADMA Biologics?
Of its last 10 fiscal years, fiscal 2024, with $197.7m.
Where does ADMA Biologics rank in its sector by net income?
It ranks 103rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for ADMA Biologics come from?
From the annual report (Form 10-K) that ADMA Biologics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that ADMA Biologics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on ADMA Biologics: the ADMA Biologics page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.